General Dermatology
Eczema
Chronic Hand Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis

Article

July 31, 2008

Obagi Medical Products presents promising in vitro data for topical C serums

Chicago - Obagi Medical Products announces in vitro data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, Skinceuticals, according to Marketwatch.com.

Chicago

- Obagi Medical Products announces

in vitro

data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, according to Marketwatch.com.

In addition, the Obagi Professional-C Serum had a five-fold greater absorption of vitamin C than the leading competitive product, and both Obagi products were proven to have a greater stability than the leading competitor.